These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 27569291)

  • 41. Genetic variants of the organic cation transporter 2 influence the disposition of metformin.
    Song IS; Shin HJ; Shim EJ; Jung IS; Kim WY; Shon JH; Shin JG
    Clin Pharmacol Ther; 2008 Nov; 84(5):559-62. PubMed ID: 18401339
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Targeted disruption of the multidrug and toxin extrusion 1 (mate1) gene in mice reduces renal secretion of metformin.
    Tsuda M; Terada T; Mizuno T; Katsura T; Shimakura J; Inui K
    Mol Pharmacol; 2009 Jun; 75(6):1280-6. PubMed ID: 19332510
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Polymorphism in human organic cation transporters and metformin action.
    Takane H; Shikata E; Otsubo K; Higuchi S; Ieiri I
    Pharmacogenomics; 2008 Apr; 9(4):415-22. PubMed ID: 18384255
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Proton pump inhibitors do not impair the effectiveness of metformin in patients with diabetes.
    Flory J; Haynes K; Leonard CE; Hennessy S
    Br J Clin Pharmacol; 2015 Feb; 79(2):330-6. PubMed ID: 25199921
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Improving oral bioavailability of metformin hydrochloride using water-in-oil microemulsions and analysis of phase behavior after dilution.
    Li Y; Song J; Tian N; Cai J; Huang M; Xing Q; Wang Y; Wu C; Hu H
    Int J Pharm; 2014 Oct; 473(1-2):316-25. PubMed ID: 25014370
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Investigation of bioequivalence of a new fixed-dose combination of acarbose and metformin with the corresponding loose combination as well as the drug-drug interaction potential between both drugs in healthy adult male subjects.
    Kim S; Jang IJ; Shin D; Shin DS; Yoon S; Lim KS; Yu KS; Li J; Zhang H; Liu Y; Brendel E; Blode H; Wang Y
    J Clin Pharm Ther; 2014 Aug; 39(4):424-31. PubMed ID: 24806030
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparative bioavailability of two oral formulations manufactured in Mexico containing glyburide and metformin in diabetic patients.
    Flores-Murrieta FJ; Aguilar-Cota ME; Camacho A; Reyes-García G; Herrera JE; Medina-Santillán R
    Proc West Pharmacol Soc; 2003; 46():82-4. PubMed ID: 14699894
    [No Abstract]   [Full Text] [Related]  

  • 48. Single nucleotide polymorphisms in the intergenic region between metformin transporter OCT2 and OCT3 coding genes are associated with short-term response to metformin monotherapy in type 2 diabetes mellitus patients.
    Zaharenko L; Kalnina I; Geldnere K; Konrade I; Grinberga S; Židzik J; Javorský M; Lejnieks A; Nikitina-Zake L; Fridmanis D; Peculis R; Radovica-Spalvina I; Hartmane D; Pugovics O; Tkáč I; Klimčáková L; Pīrāgs V; Klovins J
    Eur J Endocrinol; 2016 Dec; 175(6):531-540. PubMed ID: 27609360
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of bacterial lipopolysaccharide on the pharmacokinetics of metformin in rats.
    Choi YH; Lee I; Lee MG
    Int J Pharm; 2007 Jun; 337(1-2):194-201. PubMed ID: 17275228
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Metformin transport by a newly cloned proton-stimulated organic cation transporter (plasma membrane monoamine transporter) expressed in human intestine.
    Zhou M; Xia L; Wang J
    Drug Metab Dispos; 2007 Oct; 35(10):1956-62. PubMed ID: 17600084
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The population-specific Thr44Met OCT3 coding variant affects metformin pharmacokinetics with subsequent effects on insulin sensitivity in C57Bl/6J mice.
    Wang Q; Leask MP; Lee K; Jaiswal J; Kallingappa P; Dissanayake W; Puli'uvea C; O'Sullivan C; Watson H; Wilcox P; Murphy R; Merry TL; Shepherd PR
    Diabetologia; 2024 Oct; ():. PubMed ID: 39422716
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vitro and in vivo evaluation of a sulfenamide prodrug of basic metformin.
    Huttunen KM; Leppänen J; Vepsäläinen J; Sirviö J; Laine K; Rautio J
    J Pharm Sci; 2012 Aug; 101(8):2854-60. PubMed ID: 22648910
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effects of rabeprazole on metformin pharmacokinetics and pharmacodynamics in Chinese healthy volunteers.
    Liu G; Wen J; Guo D; Wang Z; Hu X; Tang J; Liu Z; Zhou H; Zhang W
    J Pharmacol Sci; 2016 Dec; 132(4):244-248. PubMed ID: 27245553
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibition of organic cation transporter 3 activity by tyrosine kinase inhibitors.
    Alim K; Moreau A; Bruyère A; Jouan E; Denizot C; Nies AT; Parmentier Y; Fardel O
    Fundam Clin Pharmacol; 2021 Oct; 35(5):919-929. PubMed ID: 33523504
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dose-independent pharmacokinetics of metformin in rats: Hepatic and gastrointestinal first-pass effects.
    Choi YH; Kim SG; Lee MG
    J Pharm Sci; 2006 Nov; 95(11):2543-52. PubMed ID: 16937336
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of pregnancy on the pharmacokinetics of metformin.
    Hughes RC; Gardiner SJ; Begg EJ; Zhang M
    Diabet Med; 2006 Mar; 23(3):323-6. PubMed ID: 16492218
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacokinetics and bioavailability of a metformin/glyburide tablet administered alone and with food.
    Marathe PH; Arnold ME; Meeker J; Greene DS; Barbhaiya RH
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 2):1494-502. PubMed ID: 11185672
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Amorphous solid dispersion of berberine with absorption enhancer demonstrates a remarkable hypoglycemic effect via improving its bioavailability.
    Zhaojie M; Ming Z; Shengnan W; Xiaojia B; Hatch GM; Jingkai G; Li C
    Int J Pharm; 2014 Jun; 467(1-2):50-9. PubMed ID: 24607213
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bioequivalence and pharmacokinetic comparison of 3 metformin extended/sustained release tablets in healthy Indian male volunteers.
    Batolar LS; Iqbal M; Monif T; Khuroo A; Sharma PL
    Arzneimittelforschung; 2012 Jan; 62(1):22-6. PubMed ID: 22331759
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Organic cation transporters (OCTs, MATEs), in vitro and in vivo evidence for the importance in drug therapy.
    Nies AT; Koepsell H; Damme K; Schwab M
    Handb Exp Pharmacol; 2011; (201):105-67. PubMed ID: 21103969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.